找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: International Conference on Computing, Communication, Electrical and Biomedical Systems; Arulmurugan Ramu,Chow Chee Onn,M.G. Sumithra Conf

[复制链接]
楼主: 相持不下
发表于 2025-3-23 12:27:42 | 显示全部楼层
Chaitanya Garware,Ruturaj Sutar,Krishna Londheon such a futuristic topic and in such an exciting setting (a tent buffeted by 60 mph winds). Let me begin by acknowledging the seminal contribution of our scientific forefather, Dr. Alois Alzheimer. At a meeting of the South-west Germany Psychiatrists in Tübingen in 1906, Alzheimer reported a case
发表于 2025-3-23 16:38:33 | 显示全部楼层
A. B. Gurulakshmi,N. Suresh Kumar,M. Dhivya,Rajesh Gundlapalle,Sanjeev Sharmarefractory ovarian [2,3] and breast cancer [4] in several countries, and has shown activity against after human malignancies, such as lung cancer head and neck cancer, esophageal cancer, hematological malignancies, and melanomas. However, even in patients with responding tumors, response rates have
发表于 2025-3-23 18:25:25 | 显示全部楼层
Pushkar Dubey Ph.D.,Arvind Tiwari Ph.D.,Kailash Kumar Sahu Ph.D.refractory ovarian [2,3] and breast cancer [4] in several countries, and has shown activity against after human malignancies, such as lung cancer head and neck cancer, esophageal cancer, hematological malignancies, and melanomas. However, even in patients with responding tumors, response rates have
发表于 2025-3-23 23:59:32 | 显示全部楼层
发表于 2025-3-24 02:49:40 | 显示全部楼层
Lalitha Pattabiramanrefractory ovarian [2,3] and breast cancer [4] in several countries, and has shown activity against after human malignancies, such as lung cancer head and neck cancer, esophageal cancer, hematological malignancies, and melanomas. However, even in patients with responding tumors, response rates have
发表于 2025-3-24 07:10:09 | 显示全部楼层
C. S. Nithya,K. Nirmalarefractory ovarian [2,3] and breast cancer [4] in several countries, and has shown activity against after human malignancies, such as lung cancer head and neck cancer, esophageal cancer, hematological malignancies, and melanomas. However, even in patients with responding tumors, response rates have
发表于 2025-3-24 11:45:49 | 显示全部楼层
发表于 2025-3-24 15:49:52 | 显示全部楼层
发表于 2025-3-24 22:58:23 | 显示全部楼层
发表于 2025-3-25 01:38:29 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-15 02:11
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表